Ilomedin Treatment for Patients Having Undergone Primary Percutaneous Coronary Intervention (PCI)
Status:
Completed
Trial end date:
2011-06-01
Target enrollment:
Participant gender:
Summary
Acute myocardial infarct patients with STEMI (ST-elevation on ECG) whom undergo a primary
percutaneous cardiac intervention will following the standard treatment , received low dose
of Ilomedin and to low dose of standard treatment for another 24 hours.